No Data
November 20th buyback collection | tencent, aia insurance and others have successively repurchased, with tencent spending 0.701 billion Hong Kong dollars.
According to documents disclosed by hkex on November 21, tencent (00700.HK), aia (01299.HK), among others, repurchased shares. ① Tencent (00700.HK) repurchased 1.71 million ordinary shares on November 20, involving 0.701 billion Hong Kong dollars, with a repurchase price ranging from 413.4 Hong Kong dollars to 406.6 Hong Kong dollars per share. Since the repurchase authorization resolution, the cumulative number of repurchased securities is 0.185 billion shares, accounting for 1.961% of the number of issued shares at the time of the ordinary resolution passing. ② AIA (01299.HK)
Behind the Hong Kong stock CXO's sideways oscillation, foreign investors continue to sell while domestic investors accelerate their entrance.
Recently, the public fund medical hold positions data for Q3 2024 has been gradually disclosed, with a noticeable increase in CXO positions. Additionally, the Hong Kong Stock Connect funds have significantly bought CXO symbol stocks in the past 60 days, reflecting the current optimistic attitude of domestic funds towards the subsequent rebound of the CXO sector.
Viva Biotech (01873) spent 0.664 million Hong Kong dollars to repurchase 0.73 million shares on November 20th.
Viva Biotech (01873) announced that on November 20, 2024, the company spent 0.664 million Hong Kong dollars to buy back...
The bullish market stimulated the Hong Kong stock pharmaceutical sector, with Laikai Pharmaceutical soaring nearly 20%.
Statistics from the Capital Research Department of Silver (Hong Kong) show that the number of innovative drugs IND and NDA has returned to growth after hitting a low in 2022. In the third quarter of this year, 1033 drug clinical approvals were granted, a 25% year-on-year increase, with a total of 8 first-class innovative drugs approved for marketing, doubling year-on-year.
November 19 stock buyback collection | tencent, aia and others have carried out buybacks, among which tencent spent 0.703 billion Hong Kong dollars.
According to the document disclosed by hkex on November 20, tencent (00700.HK), aia (01299.HK), and others repurchased shares. ① tencent (00700.HK) repurchased 1.73 million ordinary shares on November 19, involving an amount of 0.703 billion HKD, with a repurchase price between 409 HKD and 403.4 HKD per share. Since the repurchase authorization resolution, the cumulative number of securities repurchased is 0.183 billion shares, accounting for 1.943% of the number of shares issued at the time the ordinary resolution was passed. ② aia (01299.HK) repurchased 1
On November 19, viva biotech (01873.HK) spent 0.875 million Hong Kong dollars to repurchase 0.982 million shares.
Glory Meditech, on November 19, announced that it spent 0.875 million Hong Kong dollars to repurchase 0.982 million shares on November 19.
No Data
No Data